Sumita Bhaduri-McIntosh, M.D., Ph.D.
Professor, Pediatric Infectious Diseases
On This Page
About Sumita Bhaduri-McIntosh
Teaching Profile
Courses Taught
-
PHY6910 – Supervised Research
College of Liberal Arts and Sciences
-
PHY7980 – Research for Doctoral Dissertation
College of Liberal Arts and Sciences
-
PHY6905 – Individual Work
College of Liberal Arts and Sciences
-
PHY7979 – Advanced Research
College of Liberal Arts and Sciences
Board Certifications
-
Pediatric Infectious DiseasesAmerican Board of Pediatrics
Clinical Profile
Infectious Diseases, Immunodeficiency-associated cancers (transplant-related, HIV-related), Viral cancers, Infectious Mononucleosis
Specialties
- Pediatric Infectious Disease
Areas of Interest
- Congenital Cytomegalovirus
- Congenital Syphilis
- Congenital Toxoplasmosis
- Ear Infection – Chronic
- HIV/AIDS
- Herpes – Oral
- Nontuberculous Mycobacteria
- Swollen Lymph Nodes
- Traveling with Children
Research Profile
We study Epstein-Barr virus (EBV), the first human cancer-causing virus to be discovered. EBV causes infectious mononucleosis and is causal or linked to several B lymphocyte- and epithelial cell-cancers. Some of our experiments are designed to explore how EBV disturbs and exploits cellular physiology to drive unscheduled cell proliferation, a central feature of cancer. Other experiments are directed at understanding how this virus persists successfully in over 95% of humans. Both lines of investigation have revealed several targets for anti-cancer and anti-viral intervention.
0000-0003-2946-9497
Publications
Academic Articles
Grants
-
Understanding viral mechanisms to inform oncolytic therapies for EBV-associated lymphomas in PLWH
Active
- Role:
- Principal Investigator
- Funding:
- NATL INST OF HLTH NIDCR
-
Exposing synthetic lethal vulnerabilities in EBV-positive AIDS-NHL through novel replication dependency factors
Active
- Role:
- Principal Investigator
- Funding:
- NATL INST OF HLTH NIDCR
-
Lytic Induction Project
- Role:
- Principal Investigator
- Funding:
- VIRACTA THERAPEUTICS
-
Synthetic lethal targeting of EBV-positive diffuse large B cell lymphomas in persons living with HIV
Active
- Role:
- Principal Investigator
- Funding:
- NATL INST OF HLTH NCI
-
Studying the capacity of the EBV protein kinase (BGLF4) plus ganciclovir vs acyclovir to induce cell killing in non-EBV infected A549 cells.
- Role:
- Principal Investigator
- Funding:
- VIRACTA THERAPEUTICS
-
Studying the capacity of the EBV protein kinase (BGLF4) plus ganciclovir to induce cell killing in non-EBV infected 293 cells.
- Role:
- Principal Investigator
- Funding:
- VIRACTA THERAPEUTICS
-
Nanotinostat and ganciclovir in an oncolytic strategy against EBV-lymphomas
- Role:
- Principal Investigator
- Funding:
- VIRACTA THERAPEUTICS
-
Epstein-Barr virus and B-cell co-opted functions of the endogenous retrovirus envelope protein, Syncytin-1
- Role:
- Other
- Funding:
- NATL INST OF HLTH NIDCR
-
Host determinants of Epstein-Barr virus lytic cycle activation
- Role:
- Principal Investigator
- Funding:
- NATL INST OF HLTH NIAID
Contact Details
- Business:
- (352) 294-8591
- Business:
- sbhaduri@peds.ufl.edu
- Business Mailing:
-
PO Box 100296
GAINESVILLE FL 32610 - Business Street:
-
1600 SW ARCHER RD
GAINESVILLE FL 32610